Piper Sandler Downgrades Repro Med Systems (KRMD) to Neutral
- Wall Street ends week positively; S&P 500, Dow hit record highs
- Bitcoin (BTC) Drops 3% as Turkey Bans Cryptocurrency Payments Citing Lack of Regulatory Supervision
- Morgan Stanley (MS) Archegos-Related Loss Appears to be $911M
- Dollar at 4-week low on retreating Treasury yields
- J&J (JNJ) Privately Asked Rival Covid-19 Vaccine Makers to Inspect Clotting Risks, AstraZeneca (AZN) Said Yes but Pfizer (PFE) and Moderna (MRNA) Declined - Report
Piper Sandler analyst Matthew O'Brien downgraded Repro Med Systems (NASDAQ: KRMD) from Overweight to Neutral with a price target of $4.50 (from $9.00).
Shares of Repro Med Systems closed at $5.18 yesterday.
You May Also Be Interested In
- Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Lordstown Motors, Root, Vroom, and Repro Med and Encourages Investors to Contact the Firm
- Origin Energy Ltd. (ORG:AU) (OGFGY) PT Lowered to AUD6.50 at Goldman Sachs
- First Financial Holding Co Ltd (2892:TT) PT Raised to TWD18.16 at Goldman Sachs
Create E-mail Alert Related CategoriesAnalyst PT Change, Downgrades
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!